[
  {
    "ts": null,
    "headline": "Eli Lilly (NYSE:LLY) Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America",
    "summary": "Eli Lilly (NYSE:LLY) recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, showcasing significant progress in oncology treatments for ovarian cancer. Additionally, the acquisition of Cialis rights in Latin America by Grünenthal highlights a strategic shift in their partnership. Over the past week, Eli Lilly's share price rose by 5%, slightly above the market's 2% increase. While the recent positive news in oncology and the acquisition may have...",
    "url": "https://finnhub.io/api/news?id=f1b65073a9035df6c82465d384e14db25f82539f648a12f9d6cd169e6e5170ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748972501,
      "headline": "Eli Lilly (NYSE:LLY) Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America",
      "id": 135000181,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (NYSE:LLY) recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, showcasing significant progress in oncology treatments for ovarian cancer. Additionally, the acquisition of Cialis rights in Latin America by Grünenthal highlights a strategic shift in their partnership. Over the past week, Eli Lilly's share price rose by 5%, slightly above the market's 2% increase. While the recent positive news in oncology and the acquisition may have...",
      "url": "https://finnhub.io/api/news?id=f1b65073a9035df6c82465d384e14db25f82539f648a12f9d6cd169e6e5170ce"
    }
  },
  {
    "ts": null,
    "headline": "Top 50 High-Quality Dividend Stocks For June 2025",
    "summary": "Track 50 top dividend growth stocks with daily valuation updates. Discover upgrades like Ferrari & Accenture, outperforming SPY & SCHD in 2023.",
    "url": "https://finnhub.io/api/news?id=019d2eb701e479ef25b7438df3bdf4961a9d2ab247e89a75ca9759239fdf6f7e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748955192,
      "headline": "Top 50 High-Quality Dividend Stocks For June 2025",
      "id": 134980969,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189850011/image_2189850011.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Track 50 top dividend growth stocks with daily valuation updates. Discover upgrades like Ferrari & Accenture, outperforming SPY & SCHD in 2023.",
      "url": "https://finnhub.io/api/news?id=019d2eb701e479ef25b7438df3bdf4961a9d2ab247e89a75ca9759239fdf6f7e"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: encouraging results in ovarian cancer",
    "summary": "Eli Lilly announces promising Phase 1 data for its antibody-drug conjugate targeting the alpha folate receptor , LY4170156, in platinum-resistant ovarian cancer. In heavily pretreated patients,...",
    "url": "https://finnhub.io/api/news?id=d405b2678b3e2fd95d30aab08d7cef2423bf7d05e74b2850d0c2a2973d55446f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748939711,
      "headline": "Eli Lilly: encouraging results in ovarian cancer",
      "id": 134976499,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly announces promising Phase 1 data for its antibody-drug conjugate targeting the alpha folate receptor , LY4170156, in platinum-resistant ovarian cancer. In heavily pretreated patients,...",
      "url": "https://finnhub.io/api/news?id=d405b2678b3e2fd95d30aab08d7cef2423bf7d05e74b2850d0c2a2973d55446f"
    }
  },
  {
    "ts": null,
    "headline": "Exclusive-Wegovy use up 50% among US teens",
    "summary": "LOS ANGELES -American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with...",
    "url": "https://finnhub.io/api/news?id=8d5d74d3e7294bf561d22a6f0fefd4337174639b19cc296966dcbef0442dd643",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748930475,
      "headline": "Exclusive-Wegovy use up 50% among US teens",
      "id": 134975211,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "LOS ANGELES -American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with...",
      "url": "https://finnhub.io/api/news?id=8d5d74d3e7294bf561d22a6f0fefd4337174639b19cc296966dcbef0442dd643"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Jumps 6.2% In May To Log Best Month Since 2023",
    "summary": "US stocks broadly jumped in May, with the S&P 500 registering its best month in over a year.",
    "url": "https://finnhub.io/api/news?id=a87240eac9e4b5631212549d6a8180fb3c398d5bc6b3143c67d4a7e62c2fce33",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748929140,
      "headline": "S&P 500 Jumps 6.2% In May To Log Best Month Since 2023",
      "id": 134975020,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1259980515/image_1259980515.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "US stocks broadly jumped in May, with the S&P 500 registering its best month in over a year.",
      "url": "https://finnhub.io/api/news?id=a87240eac9e4b5631212549d6a8180fb3c398d5bc6b3143c67d4a7e62c2fce33"
    }
  }
]